Pain Therapeutics appeals FDA decision on REMOXY
Pain Therapeutics announced it has petitioned the FDA regarding a Complete Response Letter for REMOXY issued August 2018. The FDA and the Company have agreed to meet in-person on January 31, 2019 to discuss this matter. November 12, 2018